Speaker Profile

Ph.D., M.D., Chief Medical Officer, Beverly Hills Institute for Precision Medicine

Dr. Stanford’s clinical practice is focused on providing consultative services to primary care providers for the purposes of the integration of precision medicine into primary care plans. This approach is novel from its comprehensive nature and practical real-world implementation. Dr. Stanford began his career as a Mechanical/Aerospace Engineer at Texas Instruments in 1982. In 1991, he pivoted into biomedical science and completed the physician-scientist training program (MD/PhD) at UCLA in 1998 and internal medicine residency at UCLA in 2001. Dr. Stanford was one of the pioneers in the field of hospital medicine. In 2002, he founded and led a 25-physician group of private practice hospitalists at Cedars-Sinai Medical Center in Los Angeles and was elected by his peers to be Clinical Chief of General Internal Medicine. He completed Professional Certification in Genetics and Genomics through Stanford University in 2018 and subsequently founded the Beverly Hills Institute for Precision Medicine.

Genomic Profiling Showcase:
Beverly Hills Institute for Precision Medicine

BHIPM provides comprehensive consultative services to primary care providers and their patients for the purposes of integrating precision medicine recommendations into primary care plans.

Precision Medicine Consultation in Primary Care
This presentation provides an overview of the consultative approach taken by BHIPM in using whole genome sequencing and analysis, alongside the patient's comprehensive past medical history, extended family medical history and recent biochemical studies to inform personalized primary care plans.

 Session Abstract – PMWC 2022 Silicon Valley

Track 7, June 28-30

The PMWC 2022 Genomic Profiling Showcase will provide a 15 min speaking opportunity for selected companies working with the latest technologies in nucleic acid sequencing such as NGS, providing instrumentation for genomic sequencing, and offering direct to consumer services. These companies will share their innovative products and services to an audience of leading investors, potential clients and partners. The Genomic Profiling Showcase will exhibit the latest innovations in methods and instruments used for DNA/ RNA sequencing to ascertain the genomic and transcriptional profile of a person in order to understand why some people get certain diseases while others do not, or why people react in different ways to the same drug. This information is also being used to develop new ways to diagnose, treat, and prevent diseases, such as cancer.